Literature DB >> 22546205

An unusually cold active nitroreductase for prodrug activations.

Ayhan Çelik1, Gülden Yetiş.   

Abstract

A set of PCR primers based on the genome sequence were used to clone a gene encoding a hypothetical nitroreductases (named as Ssap-NtrB) from uropathogenic staphylococcus, Staphylococcus saprophyticus strain ATCC 15305, an oxygen insensitive flavoenzyme. Activity studies of the translation product revealed that the nitroreductase catalyses two electron reduction of a nitroaromatic drug of nitrofurazone (NFZ), cancer prodrugs of CB1954 and SN23862 at optimum temperature of 20 °C together with retaining its maximum activity considerably at 3 °C. The required electrons for such reduction could be supplied by either NADH or NADPH with a small preference for the latter. The gene was engineered for heterologous expression in Escherichia coli, and conditions were found in which the enzyme was produced in a mostly soluble form. The recombinant enzyme was purified to homogeneity and physical, spectral and catalytical properties were determined. The findings lead us to propose that Ssap-NtrB represents a novel nitro reductase with an unusual cold active property, which has not been described previously for prodrug activating enzymes of nitroreductases.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546205     DOI: 10.1016/j.bmc.2012.04.004

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

Review 1.  Psychrophilic enzymes: structural adaptation, pharmaceutical and industrial applications.

Authors:  Sepideh Parvizpour; Nurulfarhana Hussin; Mohd Shahir Shamsir; Jafar Razmara
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-11       Impact factor: 4.813

2.  Heterologous Overexpression and Biochemical Characterization of a Nitroreductase from Gluconobacter oxydans 621H.

Authors:  Yuanyuan Yang; Jinping Lin; Dongzhi Wei
Journal:  Mol Biotechnol       Date:  2016-06       Impact factor: 2.695

3.  A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy.

Authors:  Hao Wang; Xiao-Liang Zhou; Wei Long; Jin-Jian Liu; Fei-Yue Fan
Journal:  Int J Mol Sci       Date:  2015-04-28       Impact factor: 5.923

Review 4.  Discovery, Molecular Mechanisms, and Industrial Applications of Cold-Active Enzymes.

Authors:  Margarita Santiago; César A Ramírez-Sarmiento; Ricardo A Zamora; Loreto P Parra
Journal:  Front Microbiol       Date:  2016-09-09       Impact factor: 5.640

Review 5.  Hypoxia-activated prodrugs and redox-responsive nanocarriers.

Authors:  Yun Zeng; Jingwen Ma; Yonghua Zhan; Xinyi Xu; Qi Zeng; Jimin Liang; Xueli Chen
Journal:  Int J Nanomedicine       Date:  2018-10-18

Review 6.  Hypoxia-active nanoparticles used in tumor theranostic.

Authors:  Yaqin Wang; Wenting Shang; Meng Niu; Jie Tian; Ke Xu
Journal:  Int J Nanomedicine       Date:  2019-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.